When Desert Oasis Healthcare (DOHC) first partnered with Neurotrack in mid-2024, the goal was straightforward: get the right patients identified sooner. What has unfolded since then is something much bigger — a fully integrated, end-to-end dementia care model that is turning early detection into early intervention at scale.
We're proud to share new data that tells the story of what's possible when clinical innovation meets organizational commitment.
When we announced our partnership with DOHC last May, we highlighted a 29% increase in dementia diagnosis rates in just four months. That momentum has not slowed. Data presented by DOHC's clinical team at the California Society of Health-System Pharmacists meeting shows a 35% net increase in new dementia cases from the start of 2025 through September — compared to the end of 2024. Year over year, the trajectory is clear: patients who would previously have gone undetected are now being identified and connected to care.
This matters enormously in the Coachella Valley, where seniors make up roughly one in three residents — nearly double the California state average — and where national estimates suggest that up to 61% of people living with dementia remain undiagnosed.
One of the most exciting developments at DOHC isn't just who is being screened — it's what happens next. The surge in diagnoses driven by Neurotrack's cognitive screening highlighted a critical downstream need: access to specialist-level dementia care. With neurology appointments scarce across the region, DOHC took a bold and creative step, launching a dedicated Dementia Care Clinic staffed by a specialized care team to meet patients where the system had gaps.
The results of that clinic, now presented in poster format, are compelling. Of the 134 patients enrolled:
This is coordinated, proactive, patient-centered care at its best.
What DOHC has built is not just a local success story — it's a blueprint. By combining Neurotrack's digital screening with a structured clinical care pathway, they have demonstrated that a primary care medical group can take meaningful ownership of dementia care, even in resource-constrained environments.
The workflow is straightforward to replicate:
DOHC continues to screen approximately 20,000 patients per year, saves an average of 10 minutes per patient encounter over pen-and-paper assessments, and delivers Neurotrack's screener in both English and Spanish to serve the diverse community.
DOHC's team is already looking ahead. Plans include expanding clinic staffing, strengthening early referral pathways following diagnosis, and developing community partnerships. The clinic is also investing in advanced dementia care specialist training (a signal of just how committed this team is committed to gold-standard care).
At Neurotrack, we couldn't be prouder to be part of this story. Our mission has always been to transform the detection and care of dementia. Watching our partners pair our technology with the infrastructure to support patient outcomes after detection is what makes this work truly meaningful.
If your organization is ready to build a smarter, more comprehensive approach to cognitive care, we'd love to talk.